Germany Launches a 16M€ Epigenome Program in the Frame of the IHEC
News Sep 12, 2012
The German Ministry for Research and Education (BMBF) will support the German epigenome program initiative “DEEP” with a budget of 16M€ over 5 years.
DEEP will be the official German contribution to the world wide operating International Human Epigenome Consortium (IHEC).
The DEEP program will be coordinated by Prof. Dr. Jörn Walter, Saarland University.
DEEP forms a network of 21 German expert groups for interdisciplinary epigenome research.
DEEP will generate 70 reference epigenome maps of major primary cell/tissue types in normal and diseased states exclusively using NGS technologies.
The scientific program focusses on metabolic and inflammatory diseases such as adipositas, fatty liver disease, bowel disease and rheumatic arthritis.
DEEP combines strong experimental and bioinformatics expertise in epigenomics.
The goal is to generate high quality reference epigenomes which will be deposited in public repositories coordinated by IHEC.
The DEEP epigenome program will be flanked by functional model studies using mouse and human cell systems.
This combined program will produce new functional insights in the molecular processes of complex systemic diseases.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.